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Deep brain stimulation (DBS) of the ventral capsule/ventral striatum (VC/VS) reduces the
symptoms of treatment-resistant obsessive compulsive disorder (OCD), and improves
response to extinction-based therapies. We recently reported that DBS-like stimulation
of a rat homologue of VC/VS, the dorsal-VS, reduced conditioned fear and enhanced
extinction memory (Rodriguez-Romaguera et al., 2012). In contrast, DBS of the ventral-
VS had the opposite effects. To examine possible mechanisms of these effects, we
assessed the effects of VS DBS on the expression of the neural activity marker Fos
and brain-derived neurotrophic factor (BDNF), a key mediator of extinction plasticity in
prefrontal-amygdala circuits. Consistent with decreased fear expression, DBS of dorsal-
VS increased Fos expression in prelimbic and infralimbic prefrontal cortices and in the
lateral division of the central nucleus of amygdala, an area that inhibits amygdala output.
Consistent with improved extinction memory, we found that DBS of dorsal-VS, but not
ventral-VS, increased neuronal BDNF expression in prelimbic and infralimbic prefrontal
cortices. These rodent findings are consistent with the idea that clinical DBS of VC/VS
may augment fear extinction through an increase in BDNF expression.
Keywords: anxiety disorders, obsessive compulsive disorder, prefrontal cortex, amygdala, Fos, high-frequency
stimulation, fear expression
INTRODUCTION
Deep brain stimulation (DBS) of the ventral capsule/ventral stria-
tum (VC/VS) reduces the symptoms of refractory obsessive com-
pulsive disorder OCD, (Denys et al., 2010; Greenberg et al., 2010),
but little is known about the mechanisms. Many OCD com-
pulsions consist of avoidance of stimuli interpreted as threat-
ening (Pietrefesa and Coles, 2009). Avoidance behaviors persist
in the absence of danger, suggesting a deficit in extinction of
fear (Rasmussen and Eisen, 1992; Milad et al., 2013). We recently
observed in rats that DBS-like high frequency stimulation of the
VS, a rodent homologue of the VC/VS, either enhanced or weak-
ened extinction of fear, depending on the specific site within the
VS (Rodriguez-Romaguera et al., 2012). DBS of the dorsal por-
tion of the VS (dorsal-VS) reduced fear expression and enhanced
extinction memory, whereas DBS of the ventral portion of the
VS (ventral-VS) impaired extinction. The opposite effects of DBS
at these VS sites offer a unique opportunity to understand the
mechanisms of DBS in extinction. For example, DBS of dorsal-VS,
but not ventral-VS, increased expression of the plasticity marker
pERK in prefrontal and amygdala regions associated with extinc-
tion (Rodriguez-Romaguera et al., 2012).
While induction of plasticity by DBS is consistent with
enhancement of extinction memory, it tells us little about the
mechanisms involved. It is well established that BDNF is a key
mediator of synaptic plasticity in fear circuits (see Monfils et al.,
2007; Andero and Ressler, 2012 for reviews). BDNF in the baso-
lateral amygdala (BLA) and the infralimbic (IL) prefrontal cor-
tex have been associated with extinction learning (Chhatwal et al.,
2006; Bredy et al., 2007; Peters et al., 2010; Soliman et al., 2010).
Thus, BDNF could play a role in extinction-modulation by DBS.
Furthermore, OCD is associated with reduced BNDF function
(Maina et al., 2010; Fontenelle et al., 2012), and patients express-
ing a BDNF genetic polymorphism show poor response to
extinction-based therapies (Fullana et al., 2012).
We therefore used an immunocytochemical approach to com-
pare the effects of DBS of dorsal-VS vs. ventral-VS on the expres-
sion of BDNF in the medial prefrontal cortex (mPFC) and amyg-
dala. In addition to neurons, BDNF is expressed in microglia,
astrocytes, and endothelial cells (Rudge et al., 1992; Bejot et al.,
2011). Therefore, to assess neuronal BDNF, we co-labeled BDNF
antibodies with the neuronal marker NeuN. Furthermore, we
measured the expression of Fos protein in the mPFC and amyg-
dala as a marker of recent neuronal activity (Morgan et al., 1987;
Dragunow and Faull, 1989).
MATERIALS AND METHODS
SUBJECTS
Male Sprague-Dawley rats (n = 37, Harlan Laboratories) weigh-
ing ∼320 g and 12–16 weeks old were used. Animals were housed
individually in transparent polyethylene cages with standard envi-
ronmental conditions (73–75◦F and a 12 hrs light/dark cycle, light
on at 7:00 A.M.) and free access to food and water. All procedures
were approved by the Institutional Care and Use Committee from
University of Puerto Rico School of Medicine, in compliance with
the National Institutes of Health.
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SURGERY
Rats were anesthetized with isofluorane inhalant gas (5%) in an
induction chamber and positioned in a stereotaxic frame. Isoflu-
orane (2–3%) was delivered through a facemask used for anes-
thesia maintenance throughout the surgery. Animals were stereo-
taxically implanted with concentric bipolar stimulating electrodes
(NEX-100; Rhodes Medical Instruments) as previously described
(Rodriguez-Romaguera et al., 2012). Electrodes were aimed at the
dorsal portion of the ventral striatum (−6.5 mm dorsoventral
from the skull surface, ±2.0 mm mediolateral from midline, and
+1.2 mm anteroposterior from bregma) or at the ventral portion
of the ventral striatum (−8.0 mm dorsoventral, ±2.0 mm medi-
olateral, and ±1.2 mm anteroposterior) (Paxinos and Watson,
1997). After surgery, rats were allowed to recover for one week
before experiments initiated.
DEEP BRAIN STIMULATION
Rats were initially connected to the stimulation cable in their
home cage and habituated for 3 hrs on 2 consecutive days. On
the following day, rats were randomly divided to receive bilateral
monophasic DBS (100 µA, 0.1 ms pulse duration, 130 Hz, bipo-
lar) continuously during 3 hrs (DBS group) or no stimulation
(Sham control group). These parameters of stimulation were the
same as those used to facilitate extinction in our previous study
(Rodriguez-Romaguera et al., 2012). A stimulator (S88X, Grass
Instruments, USA) connected to a constant-current unit (SIC-C
Isolation Unit, Grass Instruments, USA) was used.
IMMUNOCYTOCHEMISTRY
Rats were deeply anesthetized with sodium pentobarbital (450
mg/Kg i.p.) immediately after receiving 3 hrs of DBS or sham
stimulation in their home cages. They were perfused transcar-
dially with 100 ml of 0.9% saline followed by 500 ml of 4%
paraformaldehyde in 0.1 M phosphate buffer at pH 7.4. Brains
were removed from the skull and fixed overnight in the same fix-
ative solution. The next day, brains were transferred to a solution
of 30% sucrose in 0.1 M phosphate buffer at 4◦C during 48 hrs
for cryoprotection. The brains were frozen and series of coro-
nal sections (40 µm) were cut on a cryostat (CM 1850; Leica)
and collected at different levels of mPFC and amygdala. Sections
at the level of VS were also collected, mounted in coated-gelatin
slides, stained for Nissl bodies, cover-slipped and used to deter-
mine electrode placement. Immunohistochemistry for VS sec-
tions was not assessed because previous studies have shown that
DBS of VS does not induce local changes (McCracken and Grace,
2009; van Dijk et al., 2011).
For Fos immunocytochemistry experiments, alternate sections
were initially blocked in a solution of 2% normal goat serum
(NGS, Vector Laboratories, USA) plus 0.3% triton (Triton X-
100, Sigma-Aldrich, USA) in 0.12 M potassium buffer saline
for 1 hr, as previously described in our lab (Padilla-Coreano et al.,
2012). The sections were then incubated overnight at room tem-
perature with anti-Fos serum raised in rabbit (Ab-5, Oncogene
Science, USA) at a dilution of 1:20,000. The primary anti-
serum was localized using a variation of the avidinbiotin com-
plex system. Sections were then incubated for 2 hrs at room
temperature in a solution of biotinylated goat anti-rabbit IgG
(Vector Laboratories) and placed in a mixed avidin biotin
horseradish peroxidase complex solution (ABC Elite Kit, Vector
Laboratories) for 90 min. Black immunoreactive nuclei labeled
for Fos were visualized after 10 min of exposure to a chromogen
solution containing 0.02% 3,3’ diaminobenzidine tetrahydrochlo-
ride with 0.3% nickel ammonium sulphate (DAB-Ni) in 0.05
M Tris buffer, pH 7.6, followed by a 10 min incubation period
in a chromogen solution with glucose oxidase (10%) and D-
Glucose (10%). The reaction was stopped using potassium phos-
phate buffered saline (PBS) (pH 7.4). Sections were mounted in
coated-gelatin slides, dehydrated and cover slipped. Counter sec-
tions were collected, stained for Nissl bodies, cover slipped and
used to determine the anatomical boundaries of each structure
analyzed.
For BDNF immunocytochemistry, alternate sections were ini-
tially blocked in a solution of 2% normal goat serum (NGS,
Vector Laboratories) plus 0.3% triton (Triton X-100, Sigma-
Aldrich) in 0.12 M potassium buffer saline for 1 hr, as previ-
ously described (Ou et al., 2010). Sections were then incubated
overnight at room temperature with sheep anti-BDNF antibody
(1:200,Millipore, USA) plus anti-NeuN (1:200, conjugated with
rabbit polyclonal Alexa Fluor 488, Millipore). The next day,
slices were incubated with anti-sheep fluorescent secondary anti-
body (1:200, Alexa Fluor 594, Invitrogen) for 2 hrs, mounted
in coated-gelatin slides, dehydrated and then cover-slipped with a
mountingmedium to avoid fluorescence fading (Vectashield, Vec-
tor Laboratories).
IMMUNOREACTIVITY QUANTIFICATION
Counts of the number of Fos-immunoreactive neurons were car-
ried out at 20X magnification with an Olympus microscope
(Model BX51) equipped with a digital camera. Images were gen-
erated for prelimbic cortex (PL), IL cortex, basal nucleus of
the amygdala (BA), lateral portion of the central nucleus of the
amygdala (CeL), which also included the intercalated cells (ITC),
and the medial portion of the central nucleus of the amygdala
(CeM). To be considered positive for Fos-like immunoreactivity,
the nucleus of the neurons had to be of appropriate size (area
ranging from 100 to 500 µm2) and shape (at least 50% of cir-
cularity), show brown-black staining of oxidized DAB-Ni, and be
distinct from the background. Fos positive cells were automati-
cally counted and averaged for each hemisphere at 2–3 distinct
rostrocaudal levels of each structure (Metamorph software ver-
sion 6.1). For prefrontal cortex sections, the antero-posterior lev-
els were +2.7 mm, +3.2 mm and +3.7 mm from bregma. For
amygdala sections, the antero-posterior levels were +2.3 mm and
+2.8 mm from bregma. The density of Fos positive neurons was
calculated by dividing the number of Fos positive neurons by the
total area of each region.
BDNF images were obtained using the same microscope
equipped with a fluorescent lamp (X-Cite, Series 120 Q) and
a digital camera, for the same structures quantified for Fos
immunoreactivity. Image pairs were acquired at 20X magnifica-
tion using the appropriate filter sets for green Alexa Fluor 488
or red Alexa Fluor 594 fluorescence, respectively for NeuN or
BDNF labeling. Background luminescence for all images was dig-
itally removed. The threshold was automatically adjusted and the
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percentage of overlapping area between NeuN and BDNF images
(co-labeling) was determined.
STATISTICAL ANALYSIS
Statistical significance was determined with Student’s t-test
(unpaired, two-tailed). The average of BDNF-NeuN overlapping
area or Fos positive cells for each brain hemisphere was calcu-
lated and used for group comparisons. The level of statistical
significance adopted was p < 0.05. All statistical analyses were
performed using the Statistica software package (Version 6.0,
Statsoft, Tulsa, USA).
RESULTS
We previously reported that 3 hrs of continuous DBS (130 Hz)
of dorsal-VS enhanced extinction memory, whereas the same
duration of stimulation of ventral-VS impaired extinction mem-
ory (Rodriguez-Romaguera et al., 2012). Figure 1 shows electrode
FIGURE 1 | DBS of the ventral striatum can either enhance or impair
fear extinction, depending on the site of stimulation (modified from
Rodriguez-Romaguera et al., 2012). (A) Placement of DBS electrode tips
within the dorsal-VS (orange circles) and ventral-VS (green circles). (B)
Individual data showing that DBS of dorsal-VS (n = 6) decreased fear
expression on Day 2 (DBS ON) compared to Day 1 (DBS OFF), and
enhanced extinction memory, as shown by the maintenance of low levels
of freezing on Day 3 with DBS OFF. In contrast, DBS of ventral-VS (n = 6)
increased fear expression on Day 2 (DBS ON) as compared to Day 1 (DBS
OFF) and impaired extinction memory, as shown by the maintenance of
high levels of freezing on Day 3 with DBS OFF. Data shown in blocks of two
trials.
placements and behavioral data of individual rats from our pre-
vious study. As reported, rats receiving DBS of dorsal-VS on Day
two showed reduced freezing at the start of extinction (DBS on),
and reduced freezing during the extinction memory test on Day
three (DBS off). In contrast, DBS of ventral-VS increased freezing
on Day two and impaired extinction memory on Day three.
DBS OF THE DORSAL-VS, BUT NOT VENTRAL-VS,
INCREASES FOS EXPRESSION IN PL AND IL
In a different set of rats, we compared the effects of 3 hrs of con-
tinuous DBS in the dorsal- or ventral-VS on the expression of
Fos protein in the PL and IL subregions of the mPFC, as well
as in different amygdala subnuclei: the basal nucleus (BA), CeL,
which also included ITC, CeM. As illustrated in Figure 2, DBS of
the dorsal-VS significantly increased the number of Fos positive
neurons in PL [Sham: 10; DBS of dorsal-VS: 20; t(16) = −3.13;
p = 0.007], IL [Sham: 8; DBS of dorsal-VS: 17; t(16) = −3.02;
p = 0.008], and CeL/ITC [Sham: 3; DBS of dorsal-VS: 7; t(14) =
−2.48; p = 0.03]. No significant differences were observed in the
number of Fos positive neurons in BA [Sham: 2; DBS of dorsal-
VS: 4; t(14) = −1.12; p = 0.28] or CeM [Sham: 2; DBS of dorsal-
VS: 2; t(14) = 0.26; p = 0.80].
In contrast to dorsal-VS, DBS of ventral-VS did not alter
Fos expression in PL [Sham: 9; DBS of ventral-VS: 12;
t(30) = −0.98; p = 0.34], IL [Sham: 9; DBS of ventral-VS: 11;
t(30) = −0.90; p = 0.38], or CeM [Sham: 1; DBS of ventral-
VS: 1; t(27) = 0.89; p = 0.38]. However, a significant increase
in Fos positive neurons was observed in both BA [Sham: 2;
DBS of ventral-VS: 4; t(27) = −2.20; p = 0.04] and CeL/ITC
[Sham: 1; DBS of ventral-VS: 6; t(27) = −2.67; p = 0.01, see
Figure 2]. Thus, using Fos expression as an indicator of neuronal
activity, DBS of dorsal-VS increased activity in PL and IL, whereas
DBS of ventral-VS increased activity in BA. DBS of either VS site
increased activity in CeL/ITC.
DBS OF THE DORSAL-VS, BUT NOT VENTRAL-VS,
INCREASES BDNF EXPRESSION IN PL AND IL
Similar to Fos expression, levels of neuronal BDNF in mPFC
and amygdala were altered by DBS. As illustrated in Figure 3,
DBS of the dorsal-VS significantly increased the percentage of
overlap (co-labeling) between BDNF and the neuronal marker
NeuN in both PL [Sham: 1.3%; DBS of dorsal-V: 3.3%;
t(18) = −3.57; p = 0.002] and IL [Sham: 1.4%; DBS of dorsal-
VS: 3.3%; t(18) = −4.52; p < 0.001]. Notably, no group dif-
ferences in BDNF-NeuN overlap were observed in BA [Sham:
0.6%; DBS of dorsal-VS: 0.6%; t(18) = −0.30; p = 0.77], CeM
[Sham: 2.5%; DBS of dorsal-VS: 2.0%; t(18) = 1.02; p = 0.32], or
CeL/ITC [Sham: 2.1%; DBS of dorsal-VS: 2.3%; t(18) = −0.30;
p = 0.77].
In contrast to dorsal-VS, DBS of the ventral-VS did not
alter the neuronal levels of BDNF in PL [Sham: 1.8%; DBS of
ventral-VS: 1.6%; t(18) = 0.57; p = 0.58] and IL [Sham: 1.9%;
DBS of ventral-VS: 1.8%; t(18) = 0.40; p = 0.70]. In addition, no
changes in BDNF levels were observed in CeM [Sham: 1.9%;
DBS of ventral-VS: 2.0%; t(18) = −0.19; p = 0.85] and CeL/ITC
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FIGURE 2 | DBS of dorsal-VS increases neuronal activity within
extinction circuits. (A) Placement of DBS electrode tips within the dorsal-VS
(orange circles) and ventral-VS (green circles). (B) Representative micrographs
showing Fos labeled neurons in prelimbic (PL) and infralimbic (IL) regions of
medial prefrontal cortex (mPFC, 10x magnification, left), and the lateral
portion of the central nucleus of the amygdala, including the intercalated cells
(CeL/ITC), in rats administered DBS in the dorsal-VS (Amygdala, 4x
magnification, right). (C) DBS of dorsal-VS increased Fos expression in PL, IL
and CeL/ITC, but not in BA or CeM (Sham, n = 5; DBS of dorsal-VS, n = 4). In
contrast, DBS of ventral-VS increased Fos in the basal nucleus of the
amygdala (BA) and CeL/ITC, but not in PL, IL or CeM (Sham, n = 8; DBS of
ventral-VS, n = 8). Legend: CeM = medial portion of the central nucleus of
the amygdala, cc = corpus callosum, opt = optic tract. Data shown as mean
and SEM. ∗p < 0.05 ∗∗p < 0.01.
[Sham: 2.7%; DBS of ventral-VS: 2.2%; t(18) = 0.71; p = 0.48].
However, DBS of ventral-VS significantly increased the neu-
ronal levels of BDNF in BA [Sham: 0.7%; DBS of ventral-
VS: 2.1%; t(18) = −3.56; p = 0.002, see Figure 3], in agree-
ment with Fos expression. In fact, all the areas that showed
increased Fos also showed increased BDNF, with the excep-
tion of CeL/ITC which showed increased Fos but no increase
in BDNF.
DISCUSSION
Following up on our study of DBS in dorsal-VS and ventral-
VS (Rodriguez-Romaguera et al., 2012), we used an immuno-
cytochemical approach to uncover possible mechanisms of
DBS effects on fear expression and extinction memory. We
found that DBS of dorsal-VS increased expression of Fos
and neuronal BDNF in both PL and IL subregions of
the mPFC. In contrast, DBS of ventral-VS increased the
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FIGURE 3 | DBS of dorsal-VS increases neuronal BDNF in PL and IL. (A)
Placement of DBS electrode tips within the dorsal-VS (orange circles) and
ventral-VS (green circles). (B) Representative micrographs showing IL labeling
of neuronal marker NeuN (left), BDNF (middle), and BDNF-NeuN overlap
(right, white arrows). (C) DBS of dorsal-VS increased BDNF-NeuN overlap in
PL and IL subregions of the mPFC, but not in the amygdala (Sham, n = 4;
DBS of dorsal-VS, n = 6). In contrast, DBS of ventral-VS increased
BDNF-NeuN overlap in BA, but not in PL, IL, CeM or CeL/ITC (Sham, n = 5;
DBS of ventral-VS, n = 5). Legend: CeM = medial portion of the central
nucleus of the amygdala, CeL = lateral portion of the central nucleus of the
amygdala, ITC = intercalated cells. Data shown as mean and SEM.
∗∗p < 0.01.
expression of Fos and BDNF only in BA. Increased Fos
expression in CeL/ITC was observed after DBS of both dorsal-VS
or ventral-VS. Our data suggest that enhanced extinction memory
observed with DBS of dorsal-VS may be due to increased BDNF
levels in IL neurons, leading to increased activation of inhibitory
neurons in CeL/ITC (Figure 4).
Recent findings suggest that PL and IL cortices have
opposite effects on fear responses (Vidal-Gonzalez et al.,
2006; Laurent and Westbrook, 2009; Sierra-Mercado et al.,
2011). PL sends excitatory projections to BA (Vertes, 2004;
Likhtik et al., 2005), a region necessary for fear expression
(Anglada-Figueroa and Quirk, 2005), whereas IL projects
Frontiers in Behavioral Neuroscience www.frontiersin.org August 2013 | Volume 7 | Article 102 | 5
Do-Monte et al. Striatal DBS increases prefrontal BDNF
FIGURE 4 | Suggested models of how DBS of dorsal-VS and ventral-VS
affect fear. (A) Middle: DBS of dorsal-VS (ON) increases neuronal activity
(Fos) in the IL-CeLoff circuit, decreasing freezing to a conditioned tone. Right:
DBS of dorsal-VS also increases BDNF in IL and induces plasticity (pERK) in IL
and CeLoff (Rodriguez-Romaguera et al., 2012), thereby enhancing extinction
memory in the absence of DBS. (B) Middle: DBS of ventral-VS increases
neuronal activity (Fos) in the BA-CeLon circuit, increasing freezing to a
conditioned tone. Right: DBS of ventral-VS also increases BDNF in BA,
thereby impairing extinction memory in the absence
of DBS.
to GABAergic (gamma-aminobutyric acid) cells in CeL,
which inhibits CeM outputs and consequently fear expres-
sion (Royer and Pare, 2002; Quirk et al., 2003; Amano et al.,
2010). It was somewhat surprising, therefore, that dorsal-VS
DBS increased Fos expression in PL as well as IL. Optogenetic
activation of IL pyramidal neurons has been shown to reduce
PL activity through feed-forward inhibition (Ji and Neugebauer,
2012). Therefore, increased Fos in PL may reflect augmented
GABAergic activity in PL. In addition, extinction training
increases Fos expression in both PL and IL, as well as CeL/ITC
(Santini et al., 2004; Knapska and Maren, 2009; Kim et al., 2010;
Plendl and Wotjak, 2010), similar to what we observed for
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DBS of dorsal-VS. In contrast, DBS of ventral-VS increased
Fos expression in BA, consistent with increased fear expres-
sion (Amano et al., 2011; Sangha et al., 2013). BA projections
to VS terminate in the ventral-VS, rather than the dorsal-VS
(Kelley et al., 1982; Mcdonald, 1991), suggesting that increased
BA activity may be due to antidromic activation of BA fear
neurons (Herry et al., 2008), by DBS of ventral-VS. Surprisingly,
DBS of ventral-VS also increased Fos expression in CeL/ITC,
suggesting that DBS at this site may be activating a different pop-
ulation of CeL neurons mediating fear expression (Ciocchi et al.,
2010). Alternatively, both PL and IL project through the VS to
reach the amygdala (St Onge et al., 2012). Thus, stimulation of
distinct prefrontal-amygdalar fibers passing through the VS could
explain the opposite effects of adjacent DBS sites, however more
studies are needed to address this possibility.
Previous studies have shown that extinction training increases
BDNF gene expression in themPFC (Bredy et al., 2007), and infu-
sion of BDNF into IL facilitates extinction learning (Peters et al.,
2010). Furthermore, a common polymorphism in the BDNF
gene has been associated with deficits in extinction memory
in both mice and humans (Soliman et al., 2010). In particular,
the same polymorphism was associated with reduced NMDA-
glutamatergic transmission specifically in IL (Pattwell et al.,
2012). Therefore, the increase in IL BDNF following DBS of
dorsal-VS, but not ventral-VS, may mediate the enhancement
of fear extinction by DBS. DBS of dorsal-VS also increased
BDNF levels in PL, however prior studies have demonstrated
that extinction is unaffected by intra-PL infusion of BDNF
(Rosas-Vidal et al., 2012), or deletion of the BDNF gene in PL
(Choi et al., 2010).
In contrast to DBS of dorsal-VS, DBS of ventral-VS modi-
fied BDNF in BA, but not in prefrontal cortex. Previous studies
have shown that BDNF levels in BA are significantly increased
after fear conditioning (Rattiner et al., 2004; Ou and Gean, 2006).
In addition, blockade of BDNF signaling in the BA disrupted
acquisition of conditioned fear (Rattiner et al., 2004), and expres-
sion of BDNF in this area is necessary for maintenance of fear
memories (Ou et al., 2010). Therefore, increased BDNF levels in
BA could contribute to augmented fear memory with DBS of
ventral-VS, leading to impaired fear extinction memory in the
next day.
Extinction-based therapy is currently among the most
effective treatments for OCD (Rasmussen and Eisen, 1997;
Franklin and Foa, 2011; Olatunji et al., 2013), and DBS of the
VC/VS increases the effectiveness of such therapies (Denys et al.,
2010; de Koning et al., 2011). Serum levels of BDNF are reduced
in OCD (Maina et al., 2010; Fontenelle et al., 2012), and a
BDNF polymorphism is correlated with impaired response
to extinction-based therapy (Fullana et al., 2012), suggesting a
role of BDNF in OCD pathophysiology. OCD patients show
impaired fear extinction and reduced activity in the vmPFC,
a homologue of rodent IL (Milad et al., 2013). Thus, DBS-
induced increases in prefrontal BDNF, as well as prefrontal
monoamines (van Dijk et al., 2012), suggests that DBS of the
VC/VS in OCD patients may repair faulty prefrontal cir-
cuits (Figee et al., 2013), thereby improving extinction-based
therapy.
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